Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06857877 · ClinicalTrials.gov registry record
Arlington Aging Study
A clinical trial of Aging, sponsored by The University of Texas at Arlington.
- Recruiting
- Registry status
- 770
- Enrollment target
- 1
- Study location
NCT06857877 is a study of Aging that is actively recruiting participants, run by The University of Texas at Arlington. The registered enrollment target is 770 participants, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06857877, a study of Aging, is actively recruiting participants, sponsored by The University of Texas at Arlington.
- RECRUITING
- Registry status
- 770 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about the mechanisms causing functional decline with age, using exercise science, neuroscience, and remote monitoring. Specific aims include: Aim 1: Advance knowledge of the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability. Aim 2: Determine the effects of personal and societal factors on aging. Aim 3: Examine the influence of racial/ethnic and sex differences on the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability.
Conditions Studied
Study Locations (1)
Texas
- University of Texas Arlington - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 770 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06857877
The ClinicalTrials.gov registry entry for NCT06857877 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 770 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (65% lower). The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 0 interventions.
NCT06857877 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06857877 about?
NCT06857877 is a clinical study titled "Arlington Aging Study". The goal of this observational study is to learn about the mechanisms causing functional decline with age, using exercise science, neuroscience, and remote monitoring. Specific aims include: Aim 1: Advance knowledge of the biology of aging and its impact on the prevention, progression, and prognos...
What is the current status of trial NCT06857877?
This trial is currently recruiting. The enrollment target is 770 participants. The study started on 2024-09-01. Estimated completion is 2030-12-31.
What conditions does trial NCT06857877 study?
This clinical trial studies the following conditions: Aging.
Who is sponsoring clinical trial NCT06857877?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06857877 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.